RecruitingNCT04783701

Coronary CT Angio Evaluating Graft Patency in ACS Patients Treated With DAPT or Single ASA After CABG (CoCAP)


Sponsor

University Hospital, Linkoeping

Enrollment

360 participants

Start Date

May 17, 2021

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of this study is to compare the presence of graft patency in single aspirin vs dual anti platelet therapy (DAPT) treatment including ticagrelor in patients with acute coronary syndrome (ACS) treated with coronary artery bypass surgery (CABG). Follow up time is 12-36 months postoperatively and the patency will be evaluated with coronary computed tomography angiography (CCTA)


Eligibility

Min Age: 18 Years

Inclusion Criteria1

  • Previously included in TACSI-trial

Exclusion Criteria6

  • Highly irregular heart rhythm (i.e. atrial fibrillation)
  • Chronic kidney disease with estimated glomerular filtration rate (eGFR) \<45ml/min/1,73m2
  • Body weight \>120 kg
  • Previous severe allergic reaction (i.e. anaphylactic reaction) to iodine-based contrast agents
  • Not able to communicate
  • Not willing to participate

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(6)

Department of Heart Disease, Haukeland University Hospital

Bergen, Norway

St Olavs University Hospital

Trondheim, Norway

Department of Molecular and Clinical Medicine, Wallenberg Laboratory, Institute of Medicine

Gothenburg, Sweden

Dep of Vascular and Thoracic Surgery

Örebro, Sweden

Department of Cardiothoracic Surgery Karolinska University Hospital

Stockholm, Sweden

University Hospital Linköping

Linköping, Östergötland County, Sweden

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04783701


Related Trials